US6238348B1 - Miniature spectrometer system and method - Google Patents

Miniature spectrometer system and method Download PDF

Info

Publication number
US6238348B1
US6238348B1 US09/167,824 US16782498A US6238348B1 US 6238348 B1 US6238348 B1 US 6238348B1 US 16782498 A US16782498 A US 16782498A US 6238348 B1 US6238348 B1 US 6238348B1
Authority
US
United States
Prior art keywords
light
interventional device
wavelength
sensors
depicts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US09/167,824
Inventor
Robert J. Crowley
Mark Hamm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Scimed Inc
Original Assignee
Scimed Life Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/898,604 external-priority patent/US6119031A/en
Priority claimed from US08/922,263 external-priority patent/US20010003800A1/en
Priority claimed from US08/939,612 external-priority patent/US6185443B1/en
Priority claimed from US08/939,707 external-priority patent/US6096065A/en
Priority claimed from US08/940,464 external-priority patent/US6324418B1/en
Priority claimed from US08/939,706 external-priority patent/US5984861A/en
Priority to US09/167,824 priority Critical patent/US6238348B1/en
Application filed by Scimed Life Systems Inc filed Critical Scimed Life Systems Inc
Assigned to SCIMED LIFE SYSTEMS, INC. reassignment SCIMED LIFE SYSTEMS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CROWLEY, ROBERT J., HAMM, MARK A.
Priority to US09/691,554 priority patent/US6405073B1/en
Publication of US6238348B1 publication Critical patent/US6238348B1/en
Application granted granted Critical
Assigned to BOSTON SCIENTIFIC SCIMED, INC. reassignment BOSTON SCIENTIFIC SCIMED, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: SCIMED LIFE SYSTEMS, INC.
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • A61B18/24Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor with a catheter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0031Implanted circuitry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0071Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0075Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
    • A61B5/0084Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/6848Needles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0601Apparatus for use inside the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • A61N5/062Photodynamic therapy, i.e. excitation of an agent
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/33Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using ultraviolet light
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B17/22004Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
    • A61B17/22012Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement
    • A61B17/2202Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement the ultrasound transducer being inside patient's body at the distal end of the catheter
    • A61B2017/22021Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement the ultrasound transducer being inside patient's body at the distal end of the catheter electric leads passing through the catheter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B2018/1807Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using light other than laser radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/03Detecting, measuring or recording fluid pressure within the body other than blood pressure, e.g. cerebral pressure; Measuring pressure in body tissues or organs
    • A61B5/036Detecting, measuring or recording fluid pressure within the body other than blood pressure, e.g. cerebral pressure; Measuring pressure in body tissues or organs by means introduced into body tracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/07Endoradiosondes
    • A61B5/073Intestinal transmitters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0658Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0661Radiation therapy using light characterised by the wavelength of light used ultraviolet
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01JMEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
    • G01J3/00Spectrometry; Spectrophotometry; Monochromators; Measuring colours
    • G01J3/12Generating the spectrum; Monochromators
    • G01J2003/1213Filters in general, e.g. dichroic, band
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/314Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths
    • G01N2021/3166Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths using separate detectors and filters

Definitions

  • This invention relates to the in situ diagnosis of tissue and organs through the use of interventional spectrometry.
  • tissue autofluorescence can induce endogenous tissue fluorescence, also known as autofluorescence.
  • the spectrum emitted by tissue autofluorescence can be characteristic of a tissue's underlying condition. For example, when illuminated with 370 nm light, the spectrum emitted from normal mucosa differs from that of an adenoma. Tissue autofluorescence spectrometry can thus be employed to diagnose cancerous conditions such as adenoma. Other conditions that can be identified by tissue autofluorescence include arteriosclerosis.
  • Tissue fluorescence may be based on intrinsic properties of the tissue, or on the differential uptake of a fluorophore administered before the spectrometry is performed.
  • Interventional tissue autofluorescence spectrometry is known in the art.
  • Currently known devices locate the spectrometer at the proximal end of the interventional device, i.e. outside the patient. These devices rely on fiber optic bundles to transmit light between the analysis site and the externally-located spectrometer.
  • the limitations inherent in employing fiber optic bundles are threefold. First, they are expensive. Second, they are stiff, lacking flexibility and maneuverability. Third, they are large, requiring a relatively large diameter to transmit the necessary amount of light to and from the analysis site.
  • Currently known interventional spectrometry devices are thus limited to use in relatively large and straight passages, such as the gastrointestinal tract.
  • This invention relates to an interventional device with a spectrometer at its distal end.
  • the spectrometer can be used to perform an in vivo analysis of a tissue's fluorescence characteristics, which can be used in diagnosing conditions such as cancer.
  • the spectrometer comprises a source unit for emitting light at a certain frequency or a plurality of frequencies.
  • the spectrometer further comprises a plurality of sensors for measuring light at a plurality of frequencies.
  • the source unit comprises a light source.
  • the light source can be monochromatic or polychromatic.
  • a tungsten-halogen light is employed as a polychromatic light source.
  • a bandpass filter may be attached. The bandpass filter may allow one or more frequencies to pass through. The frequencies emitted by the source unit are selected to provide data diagnostic of a tissue's condition.
  • the source unit emits light at a frequency of 435 nm. In other embodiments, the source unit may emit light at a frequency of 420 nm, 490 nm, or any combination thereof.
  • the frequencies measured by the sensors are selected to provide data diagnostic of a tissue's condition.
  • the spectrometer comprises two sensors, which measure light at wavelengths of 370 nm and 440 nm, respectively.
  • Another object of this invention is to minimize the waste heat generated by the spectrometer.
  • the source unit emits 200 ⁇ w or less.
  • the surface of the distal end of the interventional device does not exceed a temperature of 40 degrees Celsius after 30 seconds of continuous operation.
  • the source unit is activated in brief pulses in order to keep heat down to a minimum.
  • FIG. 1 depicts a side-looking embodiment of a spectrometer comprising a 435 nm LED and two sensors.
  • FIG. 2A is an exploded cross-sectional side view of a clinically-sized end-looking device, with the cross section being taken along line A-A in FIG. 2 B.
  • FIG. 2B is an end of view of the device of FIG. 2 A.
  • FIG. 3 shows the distal end of the clinically-sized device of FIGS. 2A and 2B.
  • FIG. 4 depicts an electronics block diagram for the clinically-sized device of FIGS. 2A and 2B.
  • FIG. 5 depicts the emission spectrum of a tungsten-halogen lamp.
  • FIG. 6 depicts the excitation intensity of a filtered tungsten-halogen lamp.
  • FIG. 7 depicts a PIN photodiode response as a function of wavelength.
  • FIG. 8A depicts the wavelengths of light let through a 370 nm bandpass filter.
  • FIG. 8B depicts the wavelengths of light let through a 400 nm bandpass filter.
  • FIG. 9 depicts a testbed apparatus.
  • FIG. 10 depicts the on-channel and off-channel sensitivity of the system depicted in FIG. 9 .
  • FIG. 11 depicts the spectral response of the coumarin fluorophore to 300 nm light.
  • FIG. 12 depicts the spectral response of the PBD fluorophore to 300 nm light.
  • FIG. 13 depicts an excitation source response test setup.
  • FIG. 14 depicts an excitation source inrush and steady-state characteristics.
  • FIG. 15 depicts the exterior temperature of a probe during and after source excitation.
  • FIG. 16 depicts two possible geometric configurations for a pair of sensors.
  • FIG. 17 depicts an excitation source radiation pattern
  • FIG. 18 depicts the spatial response of a sensor pair in a coplanar configuration.
  • FIG. 19 depicts the spatial response of a sensor pair in an angled configuration.
  • FIG. 20 depicts apparatus for measuring the power output of an excitation source.
  • FIG. 21 depicts apparatus for measuring sensor efficiency.
  • the spectrometer 100 is contained in a housing 110 with a diameter of 9.3 F (0.128 inches) and a wall thickness of 0.015 inches.
  • This embodiment employs as its light source a LED 200 which emits light at a frequency of 435 nm.
  • This embodiment further employs two PIN photodiodes as sensors 150 and 160 , disposed on either side of the LED 200 . Attached to each sensor 150 and 160 is a bandpass filter 170 and 180 that lets through 370 nm and 440 nm, respectively.
  • the LED and sensors are disposed along the longitudinal axis of the housing 110 , and face in a direction perpendicular to the longitudinal axis.
  • the sensors are angled inward towards the LED 200 .
  • the housing 110 is transparent, and is designed to minimize attenuation of both excitation and emitted energy.
  • the LED 200 and the PIN photodiodes 150 and 160 are made with single layer construction.
  • the LED 200 is a LEDtronics model 435.
  • the spectrometer 100 is contained in a housing 110 with a diameter of 0.625 inches, and an overall length of 8 inches.
  • the light source 120 is a tungsten-halogen bulb 130 with a bichromatic filter 140 attached.
  • the bichromatic filter 140 only lets through light with wavelengths of 420 nm and 490 nm.
  • This embodiment employs two PIN photodiodes 150 and 160 as sensors. Attached to each sensor is a bandpass filter 170 and 180 that lets through 370 nm and 440 nm, respectively.
  • the light source 120 is disposed along the longitudinal axis of the housing 110 and faces the distal end of the housing 110 .
  • the sensors 150 and 160 face the distal end of the housing, and are disposed on either side of the longitudinal axis.
  • An end cap 190 covers the distal end of the housing. The end cap is designed to minimize attenuation of both excitation and emitted energy.
  • the sensors are angled inward about 30 degrees towards the longitudinal axis.
  • the sensors 150 and 160 , their filters 170 and 180 , as well as the light source 120 are visible through the end cap 190 .
  • FIG. 4 depicts an electronics block diagram for the embodiment depicted in FIG. 2 and FIG. 3 .
  • the test sample 400 fluoresces at wavelengths of 440 nm and 370 nm when illuminated by 300 nm light from light source 120 .
  • Filters 170 and 180 are attached to PIN photodiodes 150 and 160 , respectively.
  • Bandpass filters 170 and 180 let through light of 440 nm and 370 mn, respectively.
  • PIN photodiodes 150 and 160 emit an electrical signal in response to light. The strength of their signals is proportional to the intensity of the light shining on them. These electrical signals are sent through low pass filters 410 and 420 .
  • These filters remove 60 Hz electrical signals, and serve to increase the signal-to-noise ratio of the output of the PIN photodiodes 150 and 160 .
  • the signals are next sent to amplifiers 430 and 440 , and combined into a comparator decision process 450 .
  • the comparator decision process 450 indicates either result A 460 or result B 470 .
  • colonic tissue is diagnosed for adenoma.
  • the colon is illuminated with 325 nm light, and tissue autofluorescence readings are taken at 460 nm and 680 nm.
  • the light source operates in the “blue” region of the visible spectrum, emitting light at a wavelength or wavelengths selected from a region between 400 nm and 490 nm.
  • FIG. 5 depicts the output spectrum of a tungsten-halogen lamp.
  • the units along x-axis 500 represent the wavelength of the light emitted by the light source in nanometers.
  • the units along the y-axis 510 represent the intensity of the light in a.u.
  • the spectrum indicates that the lamp emits a useful amount of light in the 300 nm range.
  • FIG. 6 depicts output spectra of a tungsten-halogen lamp with a bichromatic filter attached.
  • the units along the x-axis 600 represent the wavelength of the light emitted by the light source in nanometers.
  • the units along the y-axis 610 represent the intensity of the light in a.u.
  • Emission curve 620 depicts the output spectrum when 7V is applied.
  • Emission curve 630 depicts the output spectrum when 6V is applied.
  • Emission curve 640 depicts the output spectrum when 5V is applied.
  • the intensity of the spectrum varies as a result of the voltage used. A large increase in light output at 300 nm is observed when the voltage is increased from 5V to 7V.
  • FIG. 7 depicts the spectrum response of a PIN photodiode.
  • the units along x-axis 700 represent the wavelength of light input into the sensor in nanometers.
  • the units along the y-axis 710 represent the response of the photodiode in A/W.
  • the PIN photodiode reacts to a broad spectrum of light.
  • FIG. 8 A and FIG. 8B depict two photoresponse curves of a PIN photodiode.
  • the units along the x-axes 800 and 820 represent the wavelength of the light input into the sensor in nanometers.
  • the y-axes 810 and 830 represent the transmission in a.u.
  • FIG. 8A depicts the photoresponse curve of a PIN photodiode with a 370 nm bandpass filter attached.
  • FIG. 8B depicts the photoresponse curve of a PIN photodiode with a 400 nm bandpass filter attached.
  • the PIN photodiode with a 370 nm bandpass filter attached responds only to a narrow range of wavelengths centered around 370 nm. Response to wavelengths outside of this range is essentially zero.
  • Response curve 850 depicts analogous results for the 400 nm bandpass filter.
  • FIG. 9 depicts a test fixture used to analyze the sensitivity and specificity of the response of the filtered PIN photodiodes.
  • a sample fluorescin is placed in a cuvette 900 .
  • a DC power supply powers filtered light source 120 .
  • Filtered light source 120 illuminates the sample fluorescin with 300 nm light.
  • the sample fluorescin fluoresces in response to the 300 nm light.
  • Photodiode assemblies 910 and 920 emit electrical signals in response to light of 370 mn and 440 nm, respectively. These electrical signals are sent to channel amplifiers 960 and 970 , where the intensities of the electrical signals are read.
  • a fiber optic bundle 930 provides access for an external spectrometer (not shown) to corroborate results.
  • the light source 120 , the cuvette 900 and the photodiode assemblies 910 and 920 are all enclosed in a light-tight metal enclosure 950 .
  • FIG. 10 depicts the response of each photodiode assembly to each fluorophore.
  • the units along the x-axis 1040 represent fluorophore concentration as a percentage in solution.
  • the units along the y-axis 1050 represent the response of the photodiodes to the light in nanoamperes.
  • Response curve 1000 depicts the response of the test fixture's 440 nm channel amplifier to coumarin, a 460 nm fluorophore.
  • Response curve 1010 depicts the response of the test fixture's 370 nm channel amplifier to PDB, a 370 nm fluorophore.
  • Response curve 1020 depicts the response of the test fixture's 440 nm channel amplifier to PDB, a 370 nm fluorophore.
  • Response curve 1030 depicts the response of the test fixture's 370 nm channel amplifier to coumarin, a 460 nm fluorophore. Intensity of coumarin fluorescence at decreases at higher concentrations due to self-absorption.
  • FIG. 11 depicts the emission spectrum of a 0.1% mixture of the fluorescin coumarin to 300 nm light.
  • the units along the x-axis 1100 represent the wavelength of the light emitted in nanometers.
  • the units along the y-axis 1110 represent the intensity of fluorescence in counts. These results indicate that the majority of coumarin's fluorescence is emitted at wavelengths around 460 nm.
  • FIG. 12 depicts the emission spectrum of a 0.1% mixture of the fluorescin PBD to 300 nm light.
  • the units along the x-axis 1200 represent the wavelength of the light emitted in nanometers.
  • the units along the y-axis 1210 represent the intensity of fluorescence in counts. These results indicate that the majority of PBD's fluorescence is emitted at wavelengths around 370 nm.
  • FIG. 13 depicts the testing apparatus used to analyze inrush and steady state response of the light source 120 to the application of power.
  • the light source 120 is powered by a DC power supply 940 set at 2.0 amps and 37 volts.
  • One channel of an oscilloscope 1300 is placed across a 25 ohm resistor 1310 placed between power supply 940 and light source 120 .
  • Photodiode 150 emits an electrical signal in response to the light output by light source 120 .
  • the electrical signal is then sent to an amplifier 960 and then to another channel of oscilloscope 1300 .
  • Light source 120 and photodiode 150 are enclosed in a light tight container 950 .
  • the signals on the two channels of the oscilloscope 1300 are analyzed to compare light output to power input.
  • Response curve 1400 depicts the intensity of the light emitted by the light source 120 .
  • Response curve 1410 depicts the current supplied to the light source 120 . From these tests, it was determined that the spectrometer would require a power supply of 10.64 watts, and that it took 400 milliseconds from the application of power for the light source to reach full intensity.
  • FIG. 15 depicts probe surface temperature as a function of time of operation.
  • the units along the x-axis 1500 represent time in seconds.
  • the units along the y-axis 1510 represent the surface temperature of the probe in degrees Celsius.
  • a J-type thermocouple (Omega Engineering, Inc., Stamford, Conn.) model 5TC-GG-J-20-36 was attached to the exterior surface of the embodiment depicted in FIG. 3 .
  • the tungsten-halogen bulb 130 of this embodiment has been demonstrated to generate a surface temperature of no more than 40 degrees Celsius after 30 seconds of continuous operation.
  • the light source 120 can be operated intermittently or with short excitation times.
  • FIG. 16 depicts two possible spatial configurations for an array pair 1600 of sensors.
  • FIG. 16 ( a ) depicts the array pair 1600 as coplanar
  • FIG. 16 ( b ) depicts the array pair 1600 angled inwards toward the light source (not shown).
  • FIG. 17 depicts the radiation pattern of the excitation source.
  • FIG. 18 depicts the response pattern for an array pair in a coplanar configuration.
  • FIG. 19 depicts the response pattern for an array pair in an inwardly angled configuration.
  • FIG. 20 depicts apparatus used to measure the power output of an excitation energy source, such as a light source.
  • the light source 120 and its filter 140 is attached to a Newport radiometer head 1720 by means of an adapter 1700 .
  • the detector 1710 measures the power output of the light source 120 .
  • the sensors are able to obtain fluorescence readings using an excitation energy as low as 200 ⁇ W.
  • FIG. 21 depicts a test fixture used to measure the response and efficiency of the PIN photodiodes.
  • a baseline value was first obtained by shining light source 120 onto reflectance standard 1800 and measuring reflected light using an advanced PhotonX detector 1820 .
  • the reflectance standard was then replaced with an uncalibrated fluorescence standard and the unfiltered photodiode 1820 was replaced with a photodiode with a bandpass filter centered at 442 nm.
  • a fluorescence signal of 4.1 nW was recorded, which is about 10% of the reflected signal from a white target.

Abstract

A miniature spectrometer can be used in situ to diagnose tissue and organs by detecting tissue autofluorescence. The miniature spectrometer is disposed at the distal end of an interventional device.

Description

RELATED APPLICATIONS
This application is based on, and claims priority to, U.S. Provisional Patent Application Serial No. 60/061,690, filed on Oct. 10, 1997, and is a continuation-in-part of U.S. patent application Ser. No. 08/903,218, filed on Jul. 22, 1997, U.S. patent application Ser. No. 08/898,604, filed on Jul. 22, 1997, U.S. patent application Ser. No. 08/922,263, filed on Sep. 2, 1997, U.S. patent application Ser. No. 08/939,612, filed on Sep. 29, 1997, U.S. patent application Ser. No. 08/940,464, filed on Sep. 29, 1997, U.S. patent application Ser. No. 08/939,707, filed on Sep. 29, 1997, and U.S. patent application Ser. No. 08/939,706, filed on Sep. 29, 1997.
TECHNICAL FIELD
This invention relates to the in situ diagnosis of tissue and organs through the use of interventional spectrometry.
BACKGROUND INFORMATION
Illumination of tissue can induce endogenous tissue fluorescence, also known as autofluorescence. The spectrum emitted by tissue autofluorescence can be characteristic of a tissue's underlying condition. For example, when illuminated with 370 nm light, the spectrum emitted from normal mucosa differs from that of an adenoma. Tissue autofluorescence spectrometry can thus be employed to diagnose cancerous conditions such as adenoma. Other conditions that can be identified by tissue autofluorescence include arteriosclerosis.
Tissue fluorescence may be based on intrinsic properties of the tissue, or on the differential uptake of a fluorophore administered before the spectrometry is performed.
Interventional tissue autofluorescence spectrometry is known in the art. Currently known devices locate the spectrometer at the proximal end of the interventional device, i.e. outside the patient. These devices rely on fiber optic bundles to transmit light between the analysis site and the externally-located spectrometer. The limitations inherent in employing fiber optic bundles are threefold. First, they are expensive. Second, they are stiff, lacking flexibility and maneuverability. Third, they are large, requiring a relatively large diameter to transmit the necessary amount of light to and from the analysis site. Currently known interventional spectrometry devices are thus limited to use in relatively large and straight passages, such as the gastrointestinal tract.
SUMMARY OF THE INVENTION
This invention relates to an interventional device with a spectrometer at its distal end. The spectrometer can be used to perform an in vivo analysis of a tissue's fluorescence characteristics, which can be used in diagnosing conditions such as cancer.
It is an object of this invention to place a spectrometer at the distal end of an interventional device with a small enough form factor to be useful in diagnosing a large variety of tissues and organs in situ.
It is a further object of this invention to provide a means of communication between the distal and proximal ends of the interventional device that is flexible and narrow, thus allowing the device to be used in a variety of passageways throughout the body. It is a further object of the invention that the means of communication be inexpensive, such as a copper wire.
The spectrometer comprises a source unit for emitting light at a certain frequency or a plurality of frequencies. The spectrometer further comprises a plurality of sensors for measuring light at a plurality of frequencies.
The source unit comprises a light source. The light source can be monochromatic or polychromatic. In one embodiment, a tungsten-halogen light is employed as a polychromatic light source. If a polychromatic light source is used, a bandpass filter may be attached. The bandpass filter may allow one or more frequencies to pass through. The frequencies emitted by the source unit are selected to provide data diagnostic of a tissue's condition. In one embodiment, the source unit emits light at a frequency of 435 nm. In other embodiments, the source unit may emit light at a frequency of 420 nm, 490 nm, or any combination thereof.
Similarly, the frequencies measured by the sensors are selected to provide data diagnostic of a tissue's condition. In one embodiment, the spectrometer comprises two sensors, which measure light at wavelengths of 370 nm and 440 nm, respectively.
Another object of this invention is to minimize the waste heat generated by the spectrometer. In one embodiment, the source unit emits 200 μw or less. In another embodiment, the surface of the distal end of the interventional device does not exceed a temperature of 40 degrees Celsius after 30 seconds of continuous operation. In one embodiment of the invention, the source unit is activated in brief pulses in order to keep heat down to a minimum.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 depicts a side-looking embodiment of a spectrometer comprising a 435 nm LED and two sensors.
FIG. 2A is an exploded cross-sectional side view of a clinically-sized end-looking device, with the cross section being taken along line A-A in FIG. 2B.
FIG. 2B is an end of view of the device of FIG. 2A.
FIG. 3 shows the distal end of the clinically-sized device of FIGS. 2A and 2B.
FIG. 4 depicts an electronics block diagram for the clinically-sized device of FIGS. 2A and 2B.
FIG. 5 depicts the emission spectrum of a tungsten-halogen lamp.
FIG. 6 depicts the excitation intensity of a filtered tungsten-halogen lamp.
FIG. 7 depicts a PIN photodiode response as a function of wavelength.
FIG. 8A depicts the wavelengths of light let through a 370 nm bandpass filter.
FIG. 8B depicts the wavelengths of light let through a 400 nm bandpass filter.
FIG. 9 depicts a testbed apparatus.
FIG. 10 depicts the on-channel and off-channel sensitivity of the system depicted in FIG. 9.
FIG. 11 depicts the spectral response of the coumarin fluorophore to 300 nm light.
FIG. 12 depicts the spectral response of the PBD fluorophore to 300 nm light.
FIG. 13 depicts an excitation source response test setup.
FIG. 14 depicts an excitation source inrush and steady-state characteristics.
FIG. 15 depicts the exterior temperature of a probe during and after source excitation.
FIG. 16 depicts two possible geometric configurations for a pair of sensors.
FIG. 17 depicts an excitation source radiation pattern
FIG. 18 depicts the spatial response of a sensor pair in a coplanar configuration.
FIG. 19 depicts the spatial response of a sensor pair in an angled configuration.
FIG. 20 depicts apparatus for measuring the power output of an excitation source.
FIG. 21 depicts apparatus for measuring sensor efficiency.
DESCRIPTION
In one embodiment, depicted in FIG. 1, the spectrometer 100 is contained in a housing 110 with a diameter of 9.3 F (0.128 inches) and a wall thickness of 0.015 inches. This embodiment employs as its light source a LED 200 which emits light at a frequency of 435 nm. This embodiment further employs two PIN photodiodes as sensors 150 and 160, disposed on either side of the LED 200. Attached to each sensor 150 and 160 is a bandpass filter 170 and 180 that lets through 370 nm and 440 nm, respectively. The LED and sensors are disposed along the longitudinal axis of the housing 110, and face in a direction perpendicular to the longitudinal axis. In a preferred embodiment, the sensors are angled inward towards the LED 200. The housing 110 is transparent, and is designed to minimize attenuation of both excitation and emitted energy. In a further preferred embodiment, the LED 200 and the PIN photodiodes 150 and 160 are made with single layer construction. In yet another embodiment, the LED 200 is a LEDtronics model 435.
In another embodiment, depicted in FIGS. 2A and 2B, the spectrometer 100 is contained in a housing 110 with a diameter of 0.625 inches, and an overall length of 8 inches. In this embodiment, the light source 120 is a tungsten-halogen bulb 130 with a bichromatic filter 140 attached. The bichromatic filter 140 only lets through light with wavelengths of 420 nm and 490 nm. This embodiment employs two PIN photodiodes 150 and 160 as sensors. Attached to each sensor is a bandpass filter 170 and 180 that lets through 370 nm and 440 nm, respectively. The light source 120 is disposed along the longitudinal axis of the housing 110 and faces the distal end of the housing 110. Similarly, the sensors 150 and 160 face the distal end of the housing, and are disposed on either side of the longitudinal axis. An end cap 190 covers the distal end of the housing. The end cap is designed to minimize attenuation of both excitation and emitted energy. In a preferred embodiment, the sensors are angled inward about 30 degrees towards the longitudinal axis.
In FIG. 3, the sensors 150 and 160, their filters 170 and 180, as well as the light source 120 are visible through the end cap 190.
FIG. 4 depicts an electronics block diagram for the embodiment depicted in FIG. 2 and FIG. 3. In this embodiment, the test sample 400 fluoresces at wavelengths of 440 nm and 370 nm when illuminated by 300 nm light from light source 120. Filters 170 and 180 are attached to PIN photodiodes 150 and 160, respectively. Bandpass filters 170 and 180 let through light of 440 nm and 370 mn, respectively. PIN photodiodes 150 and 160 emit an electrical signal in response to light. The strength of their signals is proportional to the intensity of the light shining on them. These electrical signals are sent through low pass filters 410 and 420. These filters remove 60 Hz electrical signals, and serve to increase the signal-to-noise ratio of the output of the PIN photodiodes 150 and 160. The signals are next sent to amplifiers 430 and 440, and combined into a comparator decision process 450. Depending on the signals' relative intensities, the comparator decision process 450 indicates either result A 460 or result B 470.
In an embodiment of the comparator decision process 450, colonic tissue is diagnosed for adenoma. The colon is illuminated with 325 nm light, and tissue autofluorescence readings are taken at 460 nm and 680 nm. A numeric result, C, is calculated according to the following formula, C=A * (tissue autofluorescence at 460 nm)+B * (tissue autofluorescence at 680 nm), where A and B are constants set according to the relative autofluorescent characteristics of normal and adenomous tissue. If C is above some threshold value, T, then the tissue is diagnosed as an adenoma.
In a preferred embodiment of this invention, the light source operates in the “blue” region of the visible spectrum, emitting light at a wavelength or wavelengths selected from a region between 400 nm and 490 nm.
For the purposes of tissue autofluorescence spectrometry, a light source emitting light at a wavelength of 300 nm is desirable. FIG. 5 depicts the output spectrum of a tungsten-halogen lamp. The units along x-axis 500 represent the wavelength of the light emitted by the light source in nanometers. The units along the y-axis 510 represent the intensity of the light in a.u. The spectrum indicates that the lamp emits a useful amount of light in the 300 nm range.
FIG. 6 depicts output spectra of a tungsten-halogen lamp with a bichromatic filter attached. The units along the x-axis 600 represent the wavelength of the light emitted by the light source in nanometers. The units along the y-axis 610 represent the intensity of the light in a.u. Emission curve 620 depicts the output spectrum when 7V is applied. Emission curve 630 depicts the output spectrum when 6V is applied. Emission curve 640 depicts the output spectrum when 5V is applied. The intensity of the spectrum varies as a result of the voltage used. A large increase in light output at 300 nm is observed when the voltage is increased from 5V to 7V.
For the purposes of this invention, it is necessary that the sensors are able to respond to the light at wavelengths at which the tissues to be examined autofluoresce. FIG. 7 depicts the spectrum response of a PIN photodiode. The units along x-axis 700 represent the wavelength of light input into the sensor in nanometers. The units along the y-axis 710 represent the response of the photodiode in A/W. As evidenced from the response curve 720, the PIN photodiode reacts to a broad spectrum of light.
For the purposes of this invention it is further necessary that a sensor responds only to specific wavelengths of light, and not respond to light outside its designated wavelength. FIG. 8A and FIG. 8B depict two photoresponse curves of a PIN photodiode. The units along the x-axes 800 and 820 represent the wavelength of the light input into the sensor in nanometers. The y- axes 810 and 830 represent the transmission in a.u. FIG. 8A depicts the photoresponse curve of a PIN photodiode with a 370 nm bandpass filter attached. Similarly, FIG. 8B depicts the photoresponse curve of a PIN photodiode with a 400 nm bandpass filter attached. As evidenced by photoresponse curve 840, the PIN photodiode with a 370 nm bandpass filter attached responds only to a narrow range of wavelengths centered around 370 nm. Response to wavelengths outside of this range is essentially zero. Response curve 850 depicts analogous results for the 400 nm bandpass filter.
FIG. 9 depicts a test fixture used to analyze the sensitivity and specificity of the response of the filtered PIN photodiodes. A sample fluorescin is placed in a cuvette 900. A DC power supply powers filtered light source 120. Filtered light source 120 illuminates the sample fluorescin with 300 nm light. The sample fluorescin, fluoresces in response to the 300 nm light. Photodiode assemblies 910 and 920 emit electrical signals in response to light of 370 mn and 440 nm, respectively. These electrical signals are sent to channel amplifiers 960 and 970, where the intensities of the electrical signals are read. A fiber optic bundle 930 provides access for an external spectrometer (not shown) to corroborate results. The light source 120, the cuvette 900 and the photodiode assemblies 910 and 920 are all enclosed in a light-tight metal enclosure 950.
FIG. 10 depicts the response of each photodiode assembly to each fluorophore. The units along the x-axis 1040 represent fluorophore concentration as a percentage in solution. The units along the y-axis 1050 represent the response of the photodiodes to the light in nanoamperes. Response curve 1000 depicts the response of the test fixture's 440 nm channel amplifier to coumarin, a 460 nm fluorophore. Response curve 1010 depicts the response of the test fixture's 370 nm channel amplifier to PDB, a 370 nm fluorophore. Response curve 1020 depicts the response of the test fixture's 440 nm channel amplifier to PDB, a 370 nm fluorophore. Response curve 1030 depicts the response of the test fixture's 370 nm channel amplifier to coumarin, a 460 nm fluorophore. Intensity of coumarin fluorescence at decreases at higher concentrations due to self-absorption. These results indicate that each sensor responds to its selected wavelength with a high degree of sensitivity and specificity.
FIG. 11 depicts the emission spectrum of a 0.1% mixture of the fluorescin coumarin to 300 nm light. The units along the x-axis 1100 represent the wavelength of the light emitted in nanometers. The units along the y-axis 1110 represent the intensity of fluorescence in counts. These results indicate that the majority of coumarin's fluorescence is emitted at wavelengths around 460 nm. FIG. 12 depicts the emission spectrum of a 0.1% mixture of the fluorescin PBD to 300 nm light. The units along the x-axis 1200 represent the wavelength of the light emitted in nanometers. The units along the y-axis 1210 represent the intensity of fluorescence in counts. These results indicate that the majority of PBD's fluorescence is emitted at wavelengths around 370 nm.
FIG. 13 depicts the testing apparatus used to analyze inrush and steady state response of the light source 120 to the application of power. The light source 120 is powered by a DC power supply 940 set at 2.0 amps and 37 volts. One channel of an oscilloscope 1300 is placed across a 25 ohm resistor 1310 placed between power supply 940 and light source 120. Photodiode 150 emits an electrical signal in response to the light output by light source 120. The electrical signal is then sent to an amplifier 960 and then to another channel of oscilloscope 1300. Light source 120 and photodiode 150 are enclosed in a light tight container 950. The signals on the two channels of the oscilloscope 1300 are analyzed to compare light output to power input. FIG. 14 depicts the results of these tests. Response curve 1400 depicts the intensity of the light emitted by the light source 120. Response curve 1410 depicts the current supplied to the light source 120. From these tests, it was determined that the spectrometer would require a power supply of 10.64 watts, and that it took 400 milliseconds from the application of power for the light source to reach full intensity.
For in vivo use, surface temperature needs to be moderate. FIG. 15 depicts probe surface temperature as a function of time of operation. The units along the x-axis 1500 represent time in seconds. The units along the y-axis 1510 represent the surface temperature of the probe in degrees Celsius. To obtain these measurements, a J-type thermocouple (Omega Engineering, Inc., Stamford, Conn.) model 5TC-GG-J-20-36 was attached to the exterior surface of the embodiment depicted in FIG. 3. The tungsten-halogen bulb 130 of this embodiment has been demonstrated to generate a surface temperature of no more than 40 degrees Celsius after 30 seconds of continuous operation. To prevent an undue increase in surface temperature, the light source 120 can be operated intermittently or with short excitation times.
The spatial characteristics of the sensors effect the sensitivity of the spectrometer. FIG. 16 depicts two possible spatial configurations for an array pair 1600 of sensors. FIG. 16(a) depicts the array pair 1600 as coplanar, while FIG. 16(b) depicts the array pair 1600 angled inwards toward the light source (not shown). FIG. 17 depicts the radiation pattern of the excitation source. FIG. 18 depicts the response pattern for an array pair in a coplanar configuration. FIG. 19 depicts the response pattern for an array pair in an inwardly angled configuration. These results indicate that angling the array pair may improve system sensitivity.
The spectrometer must be able to operate within certain parameters so as not to cause tissue damage. For example, it is desirable to keep the surface temperature of the spectrometer to a minimum. In order to minimize waste heat generated by the spectrometer, it is therefore desirable to obtain fluorescence readings with the minimal amount of excitation energy. FIG. 20 depicts apparatus used to measure the power output of an excitation energy source, such as a light source. In this apparatus, the light source 120 and its filter 140 is attached to a Newport radiometer head 1720 by means of an adapter 1700. The detector 1710 measures the power output of the light source 120. In a preferred embodiment of the spectrometer, the sensors are able to obtain fluorescence readings using an excitation energy as low as 200 μW.
FIG. 21 depicts a test fixture used to measure the response and efficiency of the PIN photodiodes. A baseline value was first obtained by shining light source 120 onto reflectance standard 1800 and measuring reflected light using an advanced PhotonX detector 1820. The reflectance standard was then replaced with an uncalibrated fluorescence standard and the unfiltered photodiode 1820 was replaced with a photodiode with a bandpass filter centered at 442 nm. A fluorescence signal of 4.1 nW was recorded, which is about 10% of the reflected signal from a white target.
While certain embodiments have been used to illustrate the invention, it will be recognized by those skilled in the art that various modifications can be made therein without departing from the scope of the invention as claimed.

Claims (18)

What is claimed is:
1. An interventional device having a length and a distal end and a proximal end, comprising:
a spectrometer disposed at the distal end, said spectrometer comprising
a source unit for emitting light at a wavelength sufficient to induce fluorescence of tissue,
a plurality of sensors, each of the sensors capable of detecting light at a wavelength at which the tissue fluoresces and emitting an electrical signal in response to detected light, and
electronics for processing the electrical signal emitted by each of the sensors; and
at least one electrical conduit extending from the spectrometer, within and along the length of the device, and to the proximal end of the device.
2. The interventional device of claim 1 wherein said source unit comprises a light source and a filter.
3. The interventional device of claim 2 wherein the light source comprises a tungsten-halogen lamp.
4. The interventional device of claim 2 wherein the filter comprises a bichromatic filter.
5. The interventional device of claim 4 wherein the bichromatic filter allows light of about 300 nm wavelength to pass.
6. The interventional device of claim 4 wherein the bichromatic filter allows light of about 710 mn wavelength to pass.
7. The interventional device of claim 4 wherein the bichromatic filter allows light of about 300 nm wavelength and about 710 nm wavelength to pass.
8. The interventional device of claim 1 wherein the source unit emits light at wavelengths between 420 nm and 490 nm.
9. The interventional device of claim 1 wherein one of the plurality of sensors comprises a bandpass filter that allows light of about 370 nm wavelength to pass.
10. The interventional device of claim 1 wherein one of the plurality of sensors comprises a bandpass filter that allows light of about 440 nm wavelengths to pass.
11. The interventional device of claim 1 wherein one of the plurality of sensors comprises a bandpass filter that allows light of about 370 nm wavelength to pass and another one of the plurality of sensors comprises a bandpass filter that allows light of about 440 nm wavelength to pass.
12. The interventional device of claim 1 wherein said source unit outputs an excitation power of 200 μw.
13. The interventional device of claim 1 wherein the electronics comprise an amplifier and a comparator.
14. The interventional device of claim 1 wherein a surface temperature of said distal end remains below about 40° C. in less than 30 seconds of continuous operation.
15. The interventional device of claim 1 wherein the source unit comprises
a monochromatic light source.
16. The interventional device of claim 15 wherein said monochromatic light source comprises a light-emitting diode.
17. The interventional device of claim 15 wherein said monochromatic light source emits light at a frequency of about 435 nm.
18. The interventional device of claim 15 wherein said monochromatic light source comprises a light emitting diode emitting light at a frequency of about 435 nm.
US09/167,824 1997-07-22 1998-10-07 Miniature spectrometer system and method Expired - Lifetime US6238348B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US09/167,824 US6238348B1 (en) 1997-07-22 1998-10-07 Miniature spectrometer system and method
US09/691,554 US6405073B1 (en) 1997-07-22 2000-10-18 Miniature spectrometer system and method

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US90321897A 1997-07-22 1997-07-22
US08/898,604 US6119031A (en) 1996-11-21 1997-07-22 Miniature spectrometer
US08/922,263 US20010003800A1 (en) 1996-11-21 1997-09-02 Interventional photonic energy emitter system
US08/939,707 US6096065A (en) 1997-09-29 1997-09-29 Sheath for tissue spectroscopy
US08/940,464 US6324418B1 (en) 1997-09-29 1997-09-29 Portable tissue spectroscopy apparatus and method
US08/939,612 US6185443B1 (en) 1997-09-29 1997-09-29 Visible display for an interventional device
US08/939,706 US5984861A (en) 1997-09-29 1997-09-29 Endofluorescence imaging module for an endoscope
US6169097P 1997-10-10 1997-10-10
US09/167,824 US6238348B1 (en) 1997-07-22 1998-10-07 Miniature spectrometer system and method

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US90321897A Continuation-In-Part 1996-11-21 1997-07-22

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US09/691,554 Continuation US6405073B1 (en) 1997-07-22 2000-10-18 Miniature spectrometer system and method

Publications (1)

Publication Number Publication Date
US6238348B1 true US6238348B1 (en) 2001-05-29

Family

ID=46256116

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/167,824 Expired - Lifetime US6238348B1 (en) 1997-07-22 1998-10-07 Miniature spectrometer system and method
US09/691,554 Expired - Lifetime US6405073B1 (en) 1997-07-22 2000-10-18 Miniature spectrometer system and method

Family Applications After (1)

Application Number Title Priority Date Filing Date
US09/691,554 Expired - Lifetime US6405073B1 (en) 1997-07-22 2000-10-18 Miniature spectrometer system and method

Country Status (1)

Country Link
US (2) US6238348B1 (en)

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010029328A1 (en) * 1998-01-20 2001-10-11 Crowley Robert J. Readable probe array for in-vivo use
US6324418B1 (en) * 1997-09-29 2001-11-27 Boston Scientific Corporation Portable tissue spectroscopy apparatus and method
WO2001059423A3 (en) * 2000-02-08 2002-02-28 Cornell Res Foundation Inc Multiphoton excitation through optical fibers for fluorescence spectroscopy
US6405073B1 (en) * 1997-07-22 2002-06-11 Scimed Life Systems, Inc. Miniature spectrometer system and method
US20020115918A1 (en) * 1996-11-21 2002-08-22 Crowley Robert J. Miniature spectrometer
US20030055307A1 (en) * 2001-06-04 2003-03-20 David Elmaleh Devices for detection and therapy of atheromatous plaque
US20030102153A1 (en) * 2000-02-09 2003-06-05 Matsushita Electric Industrial Co., Ltd. Transfer material method for producing the same and wiring substrate produced by using the same
US20030130562A1 (en) * 2002-01-09 2003-07-10 Scimed Life Systems, Inc. Imaging device and related methods
WO2002096484A3 (en) * 2001-05-31 2003-07-24 Infraredx Inc Apparatus and method for the optical imaging of tissue samples
US6783497B2 (en) 2002-05-23 2004-08-31 Volumetrics Medical Imaging, Inc. Two-dimensional ultrasonic array with asymmetric apertures
US20050043636A1 (en) * 2003-08-19 2005-02-24 Gaeta Alexander L. Optical fiber delivery and collection system for biological applications such as multiphoton microscopy, spectroscopy, and endoscopy
US20050283195A1 (en) * 2004-06-18 2005-12-22 Pastore Joseph M Methods and apparatuses for localizing myocardial infarction during catheterization
EP1778076A2 (en) * 2004-06-30 2007-05-02 University Of Rochester Photodynamic therapy with spatially resolved dual spectroscopic monitoring
US20070282404A1 (en) * 2006-04-10 2007-12-06 University Of Rochester Side-firing linear optic array for interstitial optical therapy and monitoring using compact helical geometry
US20090091754A1 (en) * 2007-10-05 2009-04-09 Jingyun Zhang Compact Spectrometer
US20090290766A1 (en) * 2008-05-23 2009-11-26 Placental Analytics, Llc. Automated placental measurement
US7668586B2 (en) 2000-11-02 2010-02-23 Cornell Research Foundation, Inc. In vivo multiphoton diagnostic detection and imaging of a neurodegenerative disease
US20100298688A1 (en) * 2008-10-15 2010-11-25 Dogra Vikram S Photoacoustic imaging using a versatile acoustic lens
US20100331927A1 (en) * 2007-05-02 2010-12-30 Cottrell William J Feedback-controlled method for delivering photodynamic therapy and related instrumentation
US20110117025A1 (en) * 2008-05-20 2011-05-19 Ralph Sebastian Dacosta Device and method for fluorescence-based imaging and monitoring
US8345226B2 (en) 2007-11-30 2013-01-01 Jingyun Zhang Spectrometers miniaturized for working with cellular phones and other portable electronic devices
US8353833B2 (en) 2008-07-18 2013-01-15 University Of Rochester Low-cost device for C-scan photoacoustic imaging
US20130063016A1 (en) * 2011-09-13 2013-03-14 Osram Sylvania Inc. Modified spectrum incandescent lamp
US10438356B2 (en) 2014-07-24 2019-10-08 University Health Network Collection and analysis of data for diagnostic purposes

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6185443B1 (en) * 1997-09-29 2001-02-06 Boston Scientific Corporation Visible display for an interventional device
US20040161853A1 (en) * 2003-02-13 2004-08-19 Zhongping Yang Implantable chemical sensor with rugged optical coupler
US20050165288A1 (en) * 2004-01-27 2005-07-28 Scimed Life Systems, Inc. Systems and methods for treating breast tissue
US7291824B2 (en) * 2005-12-22 2007-11-06 Palo Alto Research Center Incorporated Photosensing throughout energy range and in subranges
US7522786B2 (en) * 2005-12-22 2009-04-21 Palo Alto Research Center Incorporated Transmitting light with photon energy information
EP1793732A4 (en) * 2004-09-29 2009-11-11 Univ Delaware Ir spectrographic apparatus and method for diagnosis of disease
US9358400B2 (en) 2005-10-14 2016-06-07 Pacesetter, Inc. Leadless cardiac pacemaker
US9168383B2 (en) 2005-10-14 2015-10-27 Pacesetter, Inc. Leadless cardiac pacemaker with conducted communication
US7315667B2 (en) * 2005-12-22 2008-01-01 Palo Alto Research Center Incorporated Propagating light to be sensed
US7547904B2 (en) * 2005-12-22 2009-06-16 Palo Alto Research Center Incorporated Sensing photon energies emanating from channels or moving objects
US7420677B2 (en) * 2005-12-22 2008-09-02 Palo Alto Research Center Incorporated Sensing photon energies of optical signals
US7386199B2 (en) * 2005-12-22 2008-06-10 Palo Alto Research Center Incorporated Providing light to channels or portions
US7433552B2 (en) * 2005-12-22 2008-10-07 Palo Alto Research Center Incorporated Obtaining analyte information
US8437582B2 (en) * 2005-12-22 2013-05-07 Palo Alto Research Center Incorporated Transmitting light with lateral variation
US7358476B2 (en) * 2005-12-22 2008-04-15 Palo Alto Research Center Incorporated Sensing photons from objects in channels
US8821799B2 (en) 2007-01-26 2014-09-02 Palo Alto Research Center Incorporated Method and system implementing spatially modulated excitation or emission for particle characterization with enhanced sensitivity
US9164037B2 (en) * 2007-01-26 2015-10-20 Palo Alto Research Center Incorporated Method and system for evaluation of signals received from spatially modulated excitation and emission to accurately determine particle positions and distances
US8320983B2 (en) 2007-12-17 2012-11-27 Palo Alto Research Center Incorporated Controlling transfer of objects affecting optical characteristics
US8373860B2 (en) 2008-02-01 2013-02-12 Palo Alto Research Center Incorporated Transmitting/reflecting emanating light with time variation
US8629981B2 (en) 2008-02-01 2014-01-14 Palo Alto Research Center Incorporated Analyzers with time variation based on color-coded spatial modulation
US8527068B2 (en) 2009-02-02 2013-09-03 Nanostim, Inc. Leadless cardiac pacemaker with secondary fixation capability
US9060692B2 (en) 2010-10-12 2015-06-23 Pacesetter, Inc. Temperature sensor for a leadless cardiac pacemaker
EP2627403A4 (en) 2010-10-12 2014-03-26 Nanostim Inc Temperature sensor for a leadless cardiac pacemaker
JP2013540022A (en) 2010-10-13 2013-10-31 ナノスティム・インコーポレイテッド Leadless cardiac pacemaker with screw anti-rotation element
JP2014501136A (en) 2010-12-13 2014-01-20 ナノスティム・インコーポレイテッド Delivery catheter system and method
WO2012082755A1 (en) 2010-12-13 2012-06-21 Nanostim, Inc. Pacemaker retrieval systems and methods
EP2654889B1 (en) 2010-12-20 2017-03-01 Pacesetter, Inc. Leadless pacemaker with radial fixation mechanism
US9029800B2 (en) 2011-08-09 2015-05-12 Palo Alto Research Center Incorporated Compact analyzer with spatial modulation and multiple intensity modulated excitation sources
US8723140B2 (en) 2011-08-09 2014-05-13 Palo Alto Research Center Incorporated Particle analyzer with spatial modulation and long lifetime bioprobes
WO2013067496A2 (en) 2011-11-04 2013-05-10 Nanostim, Inc. Leadless cardiac pacemaker with integral battery and redundant welds
EP2879758B1 (en) 2012-08-01 2018-04-18 Pacesetter, Inc. Biostimulator circuit with flying cell
EP3209983A4 (en) 2014-10-23 2018-06-27 Verifood Ltd. Accessories for handheld spectrometer

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5131398A (en) 1990-01-22 1992-07-21 Mediscience Technology Corp. Method and apparatus for distinguishing cancerous tissue from benign tumor tissue, benign tissue or normal tissue using native fluorescence
WO1992012536A1 (en) 1990-12-31 1992-07-23 Research Corporation Technologies, Inc. AlGaAs NATIVE OXIDE
US5172693A (en) 1990-01-16 1992-12-22 Doody Michael C Prenatal non-invasive detection of meconium stained amniotic fluid
US5193542A (en) 1991-01-28 1993-03-16 Missanelli John S Peripartum oximetric monitoring apparatus
EP0650694A1 (en) 1993-11-01 1995-05-03 Polartechnics Ltd Method and apparatus for diseased tissue type recognition
WO1995012349A1 (en) 1993-11-05 1995-05-11 Aarnoudse, Jan, Gerard Optical, noninvasive, in-vivo measurement of properties of a constituent of a human or animal body
US5785658A (en) * 1992-09-14 1998-07-28 Sexant Medical Corporation In vivo tissue analysis methods and apparatus
WO1999022805A1 (en) 1997-10-30 1999-05-14 Microwave Medical Systems, Inc. Roller clamp-connector assembly
US5984861A (en) * 1997-09-29 1999-11-16 Boston Scientific Corporation Endofluorescence imaging module for an endoscope

Family Cites Families (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2583937A (en) 1952-01-29 Surgical exploring and operating
US2002559A (en) 1932-04-13 1935-05-28 Wappler Frederick Charles Means for surgical resection
DE888727C (en) 1941-04-22 1953-09-03 Quarzlampen Gmbh Body cavity irradiation lamp
US3176114A (en) 1962-07-16 1965-03-30 Richard F Kneisley Device for removing nasal hair
GB1485908A (en) 1974-05-21 1977-09-14 Nath G Apparatus for applying light radiation
US4075475A (en) * 1976-05-03 1978-02-21 Chemetron Corporation Programmed thermal degradation-mass spectrometry analysis method facilitating identification of a biological specimen
US4274706A (en) 1979-08-30 1981-06-23 Hughes Aircraft Company Wavelength multiplexer/demultiplexer for optical circuits
US4289966A (en) 1980-04-10 1981-09-15 The United States Of America As Represented By The Secretary Of The Army Radiation energy detector and analyzer
DE3023130A1 (en) 1980-06-20 1982-01-21 Hasso von 4000 Düsseldorf Blücher Mouth and nose steriliser - uses high intensity light flash of millisecond duration
US4340307A (en) 1980-07-07 1982-07-20 Beckman Instruments, Inc. Bichromatic spectrophotometer with wavelength reversal
JPS57175345A (en) 1981-04-22 1982-10-28 Sumitomo Electric Industries Sensor for live body organ spectrum analyser
US4472728A (en) 1982-02-19 1984-09-18 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Imaging X-ray spectrometer
JPS5940830A (en) 1982-08-31 1984-03-06 浜松ホトニクス株式会社 Apparatus for diagnosis of cancer using laser beam pulse
US4541272A (en) 1983-05-13 1985-09-17 Roland Bause Electronically controlled fuel injection system
JPS6077731A (en) 1983-10-03 1985-05-02 オリンパス光学工業株式会社 Endoscope apparatus using solid-image pick-up element
US4570638A (en) 1983-10-14 1986-02-18 Somanetics Corporation Method and apparatus for spectral transmissibility examination and analysis
US4672972A (en) 1984-08-13 1987-06-16 Berke Howard R Solid state NMR probe
US5318024A (en) 1985-03-22 1994-06-07 Massachusetts Institute Of Technology Laser endoscope for spectroscopic imaging
US5106387A (en) 1985-03-22 1992-04-21 Massachusetts Institute Of Technology Method for spectroscopic diagnosis of tissue
US4718417A (en) 1985-03-22 1988-01-12 Massachusetts Institute Of Technology Visible fluorescence spectral diagnostic for laser angiosurgery
US5034010A (en) 1985-03-22 1991-07-23 Massachusetts Institute Of Technology Optical shield for a laser catheter
US5125404A (en) 1985-03-22 1992-06-30 Massachusetts Institute Of Technology Apparatus and method for obtaining spectrally resolved spatial images of tissue
US5042494A (en) 1985-11-13 1991-08-27 Alfano Robert R Method and apparatus for detecting cancerous tissue using luminescence excitation spectra
US4930516B1 (en) 1985-11-13 1998-08-04 Laser Diagnostic Instr Inc Method for detecting cancerous tissue using visible native luminescence
US4872458A (en) 1986-09-16 1989-10-10 Olympus Optical Co., Ltd. Thermotherapy apparatus
US4902896A (en) 1987-05-08 1990-02-20 Mine Safety Appliances Company Infrared fluid analyzer
US4784158A (en) 1987-08-21 1988-11-15 Okimoto Paul M Vaginal testing applicator and method
US4894547A (en) 1987-09-28 1990-01-16 Yale University Optical method and apparatus for detecting and measuring aging, photoaging, dermal disease and pigmentation in skin
US5001556A (en) 1987-09-30 1991-03-19 Olympus Optical Co., Ltd. Endoscope apparatus for processing a picture image of an object based on a selected wavelength range
AU604567B2 (en) 1987-10-08 1990-12-20 Pacesetter Ab Implantable blood oxygen sensor and method of use
US4938602A (en) 1987-10-15 1990-07-03 Electronic Instrumentation And Technology, Inc. Automated process monitoring
US5021888A (en) 1987-12-18 1991-06-04 Kabushiki Kaisha Toshiba Miniaturized solid state imaging device
US4928172A (en) 1988-01-07 1990-05-22 Olympus Optical Co., Ltd. Endoscope output signal control device and endoscope apparatus making use of the same
US5242437A (en) 1988-06-10 1993-09-07 Trimedyne Laser Systems, Inc. Medical device applying localized high intensity light and heat, particularly for destruction of the endometrium
US4981138A (en) 1988-06-30 1991-01-01 Yale University Endoscopic fiberoptic fluorescence spectrometer
US4882623A (en) 1988-08-11 1989-11-21 Olympus Optical Co., Ltd. Signal processing apparatus for endoscope capable of changing outline enhancement frequency
US5036853A (en) 1988-08-26 1991-08-06 Polartechnics Ltd. Physiological probe
US5402778A (en) 1993-01-19 1995-04-04 Nim Incorporated Spectrophotometric examination of tissue of small dimension
US5553614A (en) 1988-12-21 1996-09-10 Non-Invasive Technology, Inc. Examination of biological tissue using frequency domain spectroscopy
US5386827A (en) 1993-03-30 1995-02-07 Nim Incorporated Quantitative and qualitative in vivo tissue examination using time resolved spectroscopy
US5555885A (en) 1988-12-21 1996-09-17 Non-Invasive Technology, Inc. Examination of breast tissue using time-resolved spectroscopy
US5187672A (en) 1989-02-06 1993-02-16 Nim Incorporated Phase modulation spectroscopic system
US5419323A (en) 1988-12-21 1995-05-30 Massachusetts Institute Of Technology Method for laser induced fluorescence of tissue
SE8900612D0 (en) 1989-02-22 1989-02-22 Jonas Johansson TISSUE CHARACTERIZATION USING A BLOOD-FREE FLUORESCENCE CRITERIA
US5421337A (en) 1989-04-14 1995-06-06 Massachusetts Institute Of Technology Spectral diagnosis of diseased tissue
US5201318A (en) 1989-04-24 1993-04-13 Rava Richard P Contour mapping of spectral diagnostics
US5009655A (en) 1989-05-24 1991-04-23 C. R. Bard, Inc. Hot tip device with optical diagnostic capability
US5024226A (en) 1989-08-17 1991-06-18 Critikon, Inc. Epidural oxygen sensor
US5045056A (en) 1989-09-15 1991-09-03 Behl Robert S Method and device for thermal ablation of hollow body organs
JP2852774B2 (en) 1989-11-22 1999-02-03 株式会社エス・エル・ティ・ジャパン Diagnostic device for living tissue and treatment device provided with the diagnostic device
DE4005743A1 (en) 1990-02-23 1991-08-29 Wolf Gmbh Richard Lithotriptor to destroy gallstones intra-or trans-luminally - has shock-wave generator, lead contg. incompressible material, and opt balloon to press generator against gall bladder
US5166755A (en) 1990-05-23 1992-11-24 Nahum Gat Spectrometer apparatus
US5062428A (en) 1990-06-04 1991-11-05 Nim Incorporated Method and device for in vivo diagnosis detecting IR emission by body organ
US5116759A (en) 1990-06-27 1992-05-26 Fiberchem Inc. Reservoir chemical sensors
US5197470A (en) 1990-07-16 1993-03-30 Eastman Kodak Company Near infrared diagnostic method and instrument
US5053033A (en) 1990-10-10 1991-10-01 Boston Advanced Technologies, Inc. Inhibition of restenosis by ultraviolet radiation
JP3164609B2 (en) 1990-10-31 2001-05-08 オリンパス光学工業株式会社 Endoscope device
EP0501034A1 (en) 1991-01-30 1992-09-02 CeramOptec GmbH Illuminated leading probe device
US5261410A (en) 1991-02-07 1993-11-16 Alfano Robert R Method for determining if a tissue is a malignant tumor tissue, a benign tumor tissue, or a normal or benign tissue using Raman spectroscopy
US5377676A (en) 1991-04-03 1995-01-03 Cedars-Sinai Medical Center Method for determining the biodistribution of substances using fluorescence spectroscopy
US5542928A (en) 1991-05-17 1996-08-06 Innerdyne, Inc. Method and device for thermal ablation having improved heat transfer
US5233621A (en) 1991-06-27 1993-08-03 Intellectual Property Development Associates Of Connecticut, Inc. Second harmonic generation and self frequency doubling laser materials comprised of bulk germanosilicate and aluminosilicate glasses
US5262645A (en) 1991-09-03 1993-11-16 General Motors Corporation Sensor for measuring alcohol content of alcohol gasoline fuel mixtures
DE4129438A1 (en) 1991-09-04 1993-03-18 Siemens Ag MEASURING ARRANGEMENT FOR THE EXAMINATION OF AN OBJECT WITH VISIBLE, NIR OR IR LIGHT
US5467767A (en) 1991-11-25 1995-11-21 Alfano; Robert R. Method for determining if tissue is malignant as opposed to non-malignant using time-resolved fluorescence spectroscopy
US5348018A (en) 1991-11-25 1994-09-20 Alfano Robert R Method for determining if tissue is malignant as opposed to non-malignant using time-resolved fluorescence spectroscopy
US5213569A (en) 1992-03-31 1993-05-25 Davis Peter L Tip for a tissue phacoemulsification device
US5512757A (en) 1992-04-06 1996-04-30 Rosemount Analytical, Inc. Spectrophotometer and optical system therefor
US5305748A (en) 1992-06-05 1994-04-26 Wilk Peter J Medical diagnostic system and related method
US5452723A (en) 1992-07-24 1995-09-26 Massachusetts Institute Of Technology Calibrated spectrographic imaging
US5206174A (en) 1992-09-24 1993-04-27 Eg&G Idaho, Inc. Method of photon spectral analysis
US5351532A (en) 1992-10-08 1994-10-04 Paradigm Technologies Methods and apparatus for making chemical concentration measurements in a sub-surface exploration probe
US5383467A (en) 1992-11-18 1995-01-24 Spectrascience, Inc. Guidewire catheter and apparatus for diagnostic imaging
US5350375A (en) 1993-03-15 1994-09-27 Yale University Methods for laser induced fluorescence intensity feedback control during laser angioplasty
JPH06285106A (en) 1993-03-30 1994-10-11 Shimadzu Corp Ultrasonic therapeutic device
US5413108A (en) 1993-04-21 1995-05-09 The Research Foundation Of City College Of New York Method and apparatus for mapping a tissue sample for and distinguishing different regions thereof based on luminescence measurements of cancer-indicative native fluorophor
US5421339A (en) 1993-05-12 1995-06-06 Board Of Regents, The University Of Texas System Diagnosis of dysplasia using laser induced fluoroescence
GB9315473D0 (en) * 1993-07-27 1993-09-08 Chemring Ltd Treatment apparatus
US5445608A (en) 1993-08-16 1995-08-29 James C. Chen Method and apparatus for providing light-activated therapy
US5456252A (en) 1993-09-30 1995-10-10 Cedars-Sinai Medical Center Induced fluorescence spectroscopy blood perfusion and pH monitor and method
US5417207A (en) 1993-12-06 1995-05-23 Sensor Devices, Inc. Apparatus for the invasive use of oximeter probes
US5405369A (en) 1994-01-25 1995-04-11 Medical College Of Ohio Photochemical ablation of gastro-intestinal tissue for augmentation of an organ
US5398844A (en) 1994-01-31 1995-03-21 Boston Scientific Corporation Multiple ligating band dispenser
JP3490760B2 (en) 1994-04-04 2004-01-26 昭 藤嶋 Tumor treatment device
US5461229A (en) 1994-06-06 1995-10-24 Unisys Corporation On-the-go optical spectroscopy soil analyzer
US5579773A (en) 1994-09-30 1996-12-03 Martin Marietta Energy Systems, Inc. Laser-induced differential normalized fluorescence method for cancer diagnosis
US5545897A (en) 1994-10-04 1996-08-13 Santa Barbara Research Center Optically-based chemical detection system
US5517313A (en) 1995-02-21 1996-05-14 Colvin, Jr.; Arthur E. Fluorescent optical sensor
US5556421A (en) 1995-02-22 1996-09-17 Intermedics, Inc. Implantable medical device with enclosed physiological parameter sensors or telemetry link
DE19506484C2 (en) 1995-02-24 1999-09-16 Stiftung Fuer Lasertechnologie Method and device for selective non-invasive laser myography (LMG)
US5571152A (en) 1995-05-26 1996-11-05 Light Sciences Limited Partnership Microminiature illuminator for administering photodynamic therapy
DE19544501A1 (en) 1995-11-29 1997-06-05 Boehringer Mannheim Gmbh Device for light reflection measurements
US5647368A (en) 1996-02-28 1997-07-15 Xillix Technologies Corp. Imaging system for detecting diseased tissue using native fluorsecence in the gastrointestinal and respiratory tract
US5785704A (en) * 1996-07-29 1998-07-28 Mrc Systems Gmbh Method for performing stereotactic laser surgery
US6119031A (en) * 1996-11-21 2000-09-12 Boston Scientific Corporation Miniature spectrometer
US6238348B1 (en) * 1997-07-22 2001-05-29 Scimed Life Systems, Inc. Miniature spectrometer system and method
US6185443B1 (en) * 1997-09-29 2001-02-06 Boston Scientific Corporation Visible display for an interventional device
US6129667A (en) * 1998-02-02 2000-10-10 General Electric Company Luminal diagnostics employing spectral analysis

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5172693A (en) 1990-01-16 1992-12-22 Doody Michael C Prenatal non-invasive detection of meconium stained amniotic fluid
US5131398A (en) 1990-01-22 1992-07-21 Mediscience Technology Corp. Method and apparatus for distinguishing cancerous tissue from benign tumor tissue, benign tissue or normal tissue using native fluorescence
WO1992012536A1 (en) 1990-12-31 1992-07-23 Research Corporation Technologies, Inc. AlGaAs NATIVE OXIDE
US5193542A (en) 1991-01-28 1993-03-16 Missanelli John S Peripartum oximetric monitoring apparatus
US5785658A (en) * 1992-09-14 1998-07-28 Sexant Medical Corporation In vivo tissue analysis methods and apparatus
EP0650694A1 (en) 1993-11-01 1995-05-03 Polartechnics Ltd Method and apparatus for diseased tissue type recognition
WO1995012349A1 (en) 1993-11-05 1995-05-11 Aarnoudse, Jan, Gerard Optical, noninvasive, in-vivo measurement of properties of a constituent of a human or animal body
US5984861A (en) * 1997-09-29 1999-11-16 Boston Scientific Corporation Endofluorescence imaging module for an endoscope
WO1999022805A1 (en) 1997-10-30 1999-05-14 Microwave Medical Systems, Inc. Roller clamp-connector assembly

Cited By (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020115918A1 (en) * 1996-11-21 2002-08-22 Crowley Robert J. Miniature spectrometer
US8126531B2 (en) 1996-11-21 2012-02-28 Boston Scientific Scimed, Inc. Miniature spectrometer
US8660637B2 (en) 1996-11-21 2014-02-25 Boston Scientific Scimed, Inc. Miniature spectrometer
US6405073B1 (en) * 1997-07-22 2002-06-11 Scimed Life Systems, Inc. Miniature spectrometer system and method
US6324418B1 (en) * 1997-09-29 2001-11-27 Boston Scientific Corporation Portable tissue spectroscopy apparatus and method
US20010029328A1 (en) * 1998-01-20 2001-10-11 Crowley Robert J. Readable probe array for in-vivo use
US8140148B2 (en) 1998-01-20 2012-03-20 Boston Scientific Scimed Ltd. Readable probe array for in vivo use
US6839586B2 (en) 2000-02-08 2005-01-04 Cornell Research Foundation, Inc. Use of multiphoton excitation through optical fibers for fluorescence spectroscopy in conjunction with optical biopsy needles and endoscopes
WO2001059423A3 (en) * 2000-02-08 2002-02-28 Cornell Res Foundation Inc Multiphoton excitation through optical fibers for fluorescence spectroscopy
US6580941B2 (en) 2000-02-08 2003-06-17 Cornell Research Foundation, Inc. Use of multiphoton excitation through optical fibers for fluorescence spectroscopy in conjunction with optical biopsy needles and endoscopes
US20030102153A1 (en) * 2000-02-09 2003-06-05 Matsushita Electric Industrial Co., Ltd. Transfer material method for producing the same and wiring substrate produced by using the same
US7668586B2 (en) 2000-11-02 2010-02-23 Cornell Research Foundation, Inc. In vivo multiphoton diagnostic detection and imaging of a neurodegenerative disease
WO2002096484A3 (en) * 2001-05-31 2003-07-24 Infraredx Inc Apparatus and method for the optical imaging of tissue samples
US6654630B2 (en) * 2001-05-31 2003-11-25 Infraredx, Inc. Apparatus and method for the optical imaging of tissue samples
AU2002305766B2 (en) * 2001-05-31 2005-09-15 Infraredx, Inc. Apparatus and method for the optical imaging of tissue samples
US20060073100A1 (en) * 2001-06-04 2006-04-06 Alan Fischman Detection and therapy of vulnerable plaque with fluorescent and/or radiolabeled compositions
US20070258906A1 (en) * 2001-06-04 2007-11-08 Fischman Alan J Methods and devices for detection and therapy of atheromatous plaque
US20030055307A1 (en) * 2001-06-04 2003-03-20 David Elmaleh Devices for detection and therapy of atheromatous plaque
US7809428B2 (en) 2001-06-04 2010-10-05 The General Hospital Corporation Devices for detection and therapy of atheromatous plaque
US8423110B2 (en) 2002-01-09 2013-04-16 Boston Scientific Scimed, Inc. Imaging device and related methods
US20030130562A1 (en) * 2002-01-09 2003-07-10 Scimed Life Systems, Inc. Imaging device and related methods
EP1575414A2 (en) * 2002-03-15 2005-09-21 The General Hospital Corporation Methods and devices for detection and therapy of atheromatous plaque
EP1575414A4 (en) * 2002-03-15 2008-02-20 Gen Hospital Corp Methods and devices for detection and therapy of atheromatous plaque
US6783497B2 (en) 2002-05-23 2004-08-31 Volumetrics Medical Imaging, Inc. Two-dimensional ultrasonic array with asymmetric apertures
US7702381B2 (en) 2003-08-19 2010-04-20 Cornell Research Foundation, Inc. Optical fiber delivery and collection method for biological applications such as multiphoton microscopy, spectroscopy, and endoscopy
US20050043636A1 (en) * 2003-08-19 2005-02-24 Gaeta Alexander L. Optical fiber delivery and collection system for biological applications such as multiphoton microscopy, spectroscopy, and endoscopy
US7640046B2 (en) * 2004-06-18 2009-12-29 Cardiac Pacemakers, Inc. Methods and apparatuses for localizing myocardial infarction during catheterization
US20100081948A1 (en) * 2004-06-18 2010-04-01 Pastore Joseph M Method and apparatus for localizing myocardial infarction during catheterization
US9008746B2 (en) 2004-06-18 2015-04-14 Cardiac Pacemakers, Inc. Method and apparatus for localizing myocardial infarction during catheterization
US20050283195A1 (en) * 2004-06-18 2005-12-22 Pastore Joseph M Methods and apparatuses for localizing myocardial infarction during catheterization
EP1778076A4 (en) * 2004-06-30 2008-03-26 Univ Rochester Photodynamic therapy with spatially resolved dual spectroscopic monitoring
US9044140B2 (en) 2004-06-30 2015-06-02 University Of Rochester Photodynamic therapy with spatially resolved dual spectroscopic monitoring
US20090043296A1 (en) * 2004-06-30 2009-02-12 University Of Rochester Photodynamic therapy with spatially resolved dual spectroscopic monitoring
EP1778076A2 (en) * 2004-06-30 2007-05-02 University Of Rochester Photodynamic therapy with spatially resolved dual spectroscopic monitoring
US20070282404A1 (en) * 2006-04-10 2007-12-06 University Of Rochester Side-firing linear optic array for interstitial optical therapy and monitoring using compact helical geometry
US20100331927A1 (en) * 2007-05-02 2010-12-30 Cottrell William J Feedback-controlled method for delivering photodynamic therapy and related instrumentation
US7817274B2 (en) 2007-10-05 2010-10-19 Jingyun Zhang Compact spectrometer
US20090091754A1 (en) * 2007-10-05 2009-04-09 Jingyun Zhang Compact Spectrometer
US8537343B2 (en) 2007-11-30 2013-09-17 Jingyun Zhang Spectrometer miniaturized for working with cellular phones and other portable electronic devices
US8345226B2 (en) 2007-11-30 2013-01-01 Jingyun Zhang Spectrometers miniaturized for working with cellular phones and other portable electronic devices
US11154198B2 (en) 2008-05-20 2021-10-26 University Health Network Method and system for imaging and collection of data for diagnostic purposes
US9042967B2 (en) 2008-05-20 2015-05-26 University Health Network Device and method for wound imaging and monitoring
US20110117025A1 (en) * 2008-05-20 2011-05-19 Ralph Sebastian Dacosta Device and method for fluorescence-based imaging and monitoring
US11375898B2 (en) 2008-05-20 2022-07-05 University Health Network Method and system with spectral filtering and thermal mapping for imaging and collection of data for diagnostic purposes from bacteria
US11284800B2 (en) 2008-05-20 2022-03-29 University Health Network Devices, methods, and systems for fluorescence-based endoscopic imaging and collection of data with optical filters with corresponding discrete spectral bandwidth
US8107710B2 (en) 2008-05-23 2012-01-31 University Of Rochester Automated placental measurement
US20090290766A1 (en) * 2008-05-23 2009-11-26 Placental Analytics, Llc. Automated placental measurement
US8353833B2 (en) 2008-07-18 2013-01-15 University Of Rochester Low-cost device for C-scan photoacoustic imaging
US8870770B2 (en) 2008-07-18 2014-10-28 University Of Rochester Low-cost device for C-scan acoustic wave imaging
US20100298688A1 (en) * 2008-10-15 2010-11-25 Dogra Vikram S Photoacoustic imaging using a versatile acoustic lens
US20130063016A1 (en) * 2011-09-13 2013-03-14 Osram Sylvania Inc. Modified spectrum incandescent lamp
US9607821B2 (en) * 2011-09-13 2017-03-28 Osram Sylvania Inc. Modified spectrum incandescent lamp
US10438356B2 (en) 2014-07-24 2019-10-08 University Health Network Collection and analysis of data for diagnostic purposes
US11676276B2 (en) 2014-07-24 2023-06-13 University Health Network Collection and analysis of data for diagnostic purposes

Also Published As

Publication number Publication date
US6405073B1 (en) 2002-06-11

Similar Documents

Publication Publication Date Title
US6238348B1 (en) Miniature spectrometer system and method
US6186780B1 (en) Method and device for the recognition of caries, plaque, concretions or bacterial infection on teeth
US5842995A (en) Spectroscopic probe for in vivo measurement of raman signals
KR100415850B1 (en) Cancer Diagnosis Device Using Laser-Induced Differential Normalized Fluorescence Spectrum
US4930516A (en) Method for detecting cancerous tissue using visible native luminescence
US7945312B2 (en) Multisensor probe for tissue identification
US6069689A (en) Apparatus and methods relating to optical systems for diagnosis of skin diseases
US5042494A (en) Method and apparatus for detecting cancerous tissue using luminescence excitation spectra
JP2004521714A (en) Methods and devices for the detection of caries, plaque, tartar, or bacterial infections in / on teeth
Sordillo et al. Optical spectral fingerprints of tissues from patients with different breast cancer histologies using a novel fluorescence spectroscopic device
Thompson et al. In vivo measurements of diffuse reflectance and time‐resolved autofluorescence emission spectra of basal cell carcinomas
Vo-Dinh et al. Laser-induced differential fluorescence for cancer diagnosis without biopsy
US6256530B1 (en) Optical instrument and technique for cancer diagnosis using in-vivo fluorescence emission of test tissue
Barr et al. Optical spectroscopy for the early diagnosis of gastrointestinal malignancy
EP1021127B1 (en) Miniature spectrometer system
JP2004526488A (en) Probes for dielectric and optical diagnostics
US8471221B2 (en) Device for measuring fluorescent radiation on biological substances with a semi-conductor sensor arrangement
JPS59189828A (en) Subcateneous measuring sensor and apparatus of blood coloring matter
Katz et al. Optical biopsy fiber-based fluorescence spectroscopy instrumentation
Vo-Dinh et al. Detection of colon malignancy using differential normalized fluorescence
Vo-Dinh et al. In-vivo cancer diagnosis of the esophagus using laser-induced fluorescence
Fang et al. Validation of a time-resolved fluorescence spectroscopy apparatus in a rabbit atherosclerosis model
Cicchi et al. Tissue classification using a fiber probe for combined Raman, fluorescence and reflectance spectroscopy
KOENIG et al. Printed zyxwvutsrqpo

Legal Events

Date Code Title Description
AS Assignment

Owner name: SCIMED LIFE SYSTEMS, INC., MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CROWLEY, ROBERT J.;HAMM, MARK A.;REEL/FRAME:010083/0061;SIGNING DATES FROM 19990603 TO 19990611

STCF Information on status: patent grant

Free format text: PATENTED CASE

FPAY Fee payment

Year of fee payment: 4

AS Assignment

Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA

Free format text: CHANGE OF NAME;ASSIGNOR:SCIMED LIFE SYSTEMS, INC.;REEL/FRAME:016480/0684

Effective date: 20041222

FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12